Importantly, IL-6 has been shown to regulate the expression of GREM1 via STAT3-dependent mechanisms in dermal fibroblasts of patients with the fibrotic condition of systemic sclerosis [33], and it is likely that a similar mechanism mediates the upregulation of stromal cell GREM1 expression observed in our study. This evidence concerns the gene GREM1 and systemic sclerosis.